Overview

Safety and Efficacy of Repeated Doses of PMI-150 (Intranasal Ketamine) in Acute Post-operative Pain Following Orthopedic Surgery

Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this research study is to evaluate the safety and analgesic efficacy of PMI-150 (intranasal ketamine) compared to placebo in patients with acute post-operative pain following orthopedic trauma, injury, or surgery.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Hospira, Inc.
Hospira, now a wholly owned subsidiary of Pfizer
Treatments:
Ketamine
Criteria
Inclusion Criteria:

- patient is scheduled for elective orthopedic surgery or procedure

Exclusion Criteria:

- patient has received an investigational drug or participated in a clinical trial
within 30 days or 5 half-lives (whichever is longer) of entering this study